annual SGA:
$49.28M+$12.26M(+33.11%)Summary
- As of today (May 29, 2025), VKTX annual SGA is $49.28 million, with the most recent change of +$12.26 million (+33.11%) on December 31, 2024.
- During the last 3 years, VKTX annual SGA has risen by +$38.58 million (+360.49%).
- VKTX annual SGA is now at all-time high.
Performance
VKTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$14.08M-$1.17M(-7.69%)Summary
- As of today (May 29, 2025), VKTX quarterly SGA is $14.08 million, with the most recent change of -$1.17 million (-7.69%) on March 31, 2025.
- Over the past year, VKTX quarterly SGA has increased by +$4.11 million (+41.20%).
- VKTX quarterly SGA is now -7.69% below its all-time high of $15.25 million, reached on December 31, 2024.
Performance
VKTX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$1.90B-$128.24M(-7.23%)Summary
- As of today (May 29, 2025), VKTX TTM SGA is -$1.90 billion, with the most recent change of -$128.24 million (-7.23%) on March 31, 2025.
- Over the past year, VKTX TTM SGA has dropped by -$1.94 billion (-5175.76%).
- VKTX TTM SGA is now -390990.70% below its all-time high of -$486.20 thousand.
Performance
VKTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
VKTX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.1% | +41.2% | -5175.8% |
| 3 y3 years | +360.5% | +281.5% | -10000.0% |
| 5 y5 years | +439.8% | +375.4% | -10000.0% |
VKTX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +360.5% | -7.7% | +281.5% | -118.3% | at low |
| 5 y | 5-year | at high | +439.8% | -7.7% | +535.0% | -277.4% | at low |
| alltime | all time | at high | >+9999.0% | -7.7% | >+9999.0% | <-9999.0% | at low |
VKTX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $14.08M(-7.7%) | $53.38M(+8.3%) |
| Dec 2024 | $49.28M(+33.1%) | $15.25M(+10.7%) | $49.28M(+15.1%) |
| Sep 2024 | - | $13.77M(+33.9%) | $42.81M(+12.9%) |
| Jun 2024 | - | $10.29M(+3.2%) | $37.92M(+1.2%) |
| Mar 2024 | - | $9.97M(+13.5%) | $37.46M(+1.2%) |
| Dec 2023 | $37.02M(+129.6%) | $8.78M(-1.2%) | $37.02M(+14.5%) |
| Sep 2023 | - | $8.89M(-9.5%) | $32.34M(+16.8%) |
| Jun 2023 | - | $9.82M(+3.1%) | $27.69M(+26.1%) |
| Mar 2023 | - | $9.53M(+132.1%) | $21.96M(+36.2%) |
| Dec 2022 | $16.12M(+50.6%) | $4.11M(-3.1%) | $16.12M(+9.8%) |
| Sep 2022 | - | $4.24M(+3.6%) | $14.68M(+12.5%) |
| Jun 2022 | - | $4.09M(+10.8%) | $13.05M(+11.6%) |
| Mar 2022 | - | $3.69M(+38.6%) | $11.70M(+9.3%) |
| Dec 2021 | $10.70M(-0.3%) | $2.66M(+2.1%) | $10.70M(+4.3%) |
| Sep 2021 | - | $2.61M(-4.7%) | $10.26M(-1.1%) |
| Jun 2021 | - | $2.74M(+1.6%) | $10.37M(-0.9%) |
| Mar 2021 | - | $2.69M(+21.5%) | $10.46M(-2.5%) |
| Dec 2020 | $10.73M(+17.6%) | $2.22M(-18.7%) | $10.73M(-1.9%) |
| Sep 2020 | - | $2.73M(-3.5%) | $10.94M(+5.5%) |
| Jun 2020 | - | $2.83M(-4.6%) | $10.37M(+6.0%) |
| Mar 2020 | - | $2.96M(+22.3%) | $9.78M(+7.1%) |
| Dec 2019 | $9.13M | $2.42M(+12.1%) | $9.13M(+5.5%) |
| Sep 2019 | - | $2.16M(-3.4%) | $8.65M(+5.5%) |
| Jun 2019 | - | $2.24M(-3.2%) | $8.20M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $2.31M(+18.6%) | $7.67M(+7.7%) |
| Dec 2018 | $7.12M(+33.6%) | $1.95M(+14.1%) | $7.12M(+8.4%) |
| Sep 2018 | - | $1.71M(+0.2%) | $6.57M(+7.9%) |
| Jun 2018 | - | $1.70M(-3.3%) | $6.09M(+7.7%) |
| Mar 2018 | - | $1.76M(+26.4%) | $5.65M(+6.0%) |
| Dec 2017 | $5.33M(+9.9%) | $1.39M(+13.6%) | $5.33M(+6.0%) |
| Sep 2017 | - | $1.23M(-3.2%) | $5.03M(+1.4%) |
| Jun 2017 | - | $1.27M(-12.1%) | $4.96M(+1.2%) |
| Mar 2017 | - | $1.44M(+32.2%) | $4.90M(+1.0%) |
| Dec 2016 | $4.85M(-3.6%) | $1.09M(-6.0%) | $4.85M(-6.0%) |
| Sep 2016 | - | $1.16M(-3.9%) | $5.16M(-10.7%) |
| Jun 2016 | - | $1.21M(-13.2%) | $5.78M(-5.2%) |
| Mar 2016 | - | $1.39M(-0.8%) | $6.10M(+21.2%) |
| Dec 2015 | $5.03M(+304.0%) | $1.40M(-21.3%) | $5.03M(+31.0%) |
| Sep 2015 | - | $1.78M(+16.7%) | $3.84M(+58.7%) |
| Jun 2015 | - | $1.53M(+373.8%) | $2.42M(+71.9%) |
| Mar 2015 | - | $322.10K(+52.8%) | $1.41M(+13.0%) |
| Dec 2014 | $1.24M(+1290.9%) | $210.80K(-41.5%) | $1.24M(+20.4%) |
| Sep 2014 | - | $360.40K(-29.9%) | $1.03M(+53.5%) |
| Jun 2014 | - | $514.00K(+221.9%) | $673.70K(+288.7%) |
| Mar 2014 | - | $159.70K(+1074.3%) | $173.30K(+204.0%) |
| Dec 2013 | $89.50K | - | - |
| Jun 2013 | - | $13.60K(+423.1%) | $57.00K(+31.3%) |
| Mar 2013 | - | $2600.00(-93.6%) | $43.40K(+6.4%) |
| Dec 2012 | - | $40.80K | $40.80K |
FAQ
- What is Viking Therapeutics annual SGA?
- What is the all time high annual SGA for Viking Therapeutics?
- What is Viking Therapeutics annual SGA year-on-year change?
- What is Viking Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Viking Therapeutics?
- What is Viking Therapeutics quarterly SGA year-on-year change?
- What is Viking Therapeutics TTM SGA?
- What is the all time high TTM SGA for Viking Therapeutics?
- What is Viking Therapeutics TTM SGA year-on-year change?
What is Viking Therapeutics annual SGA?
The current annual SGA of VKTX is $49.28M
What is the all time high annual SGA for Viking Therapeutics?
Viking Therapeutics all-time high annual SGA is $49.28M
What is Viking Therapeutics annual SGA year-on-year change?
Over the past year, VKTX annual SGA has changed by +$12.26M (+33.11%)
What is Viking Therapeutics quarterly SGA?
The current quarterly SGA of VKTX is $14.08M
What is the all time high quarterly SGA for Viking Therapeutics?
Viking Therapeutics all-time high quarterly SGA is $15.25M
What is Viking Therapeutics quarterly SGA year-on-year change?
Over the past year, VKTX quarterly SGA has changed by +$4.11M (+41.20%)
What is Viking Therapeutics TTM SGA?
The current TTM SGA of VKTX is -$1.90B
What is the all time high TTM SGA for Viking Therapeutics?
Viking Therapeutics all-time high TTM SGA is -$486.20K
What is Viking Therapeutics TTM SGA year-on-year change?
Over the past year, VKTX TTM SGA has changed by -$1.94B (-5175.76%)